Actively Recruiting
Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes
Led by Shanghai 6th People's Hospital · Updated on 2026-04-13
148
Participants Needed
15
Research Sites
102 weeks
Total Duration
On this page
Sponsors
S
Shanghai 6th People's Hospital
Lead Sponsor
S
Shenzhen Center for Chronic Disease Control
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if continuous glucose monitoring system works to improve glucose control in non-insulin-treated older adults with type 2 diabetes. The main questions it aims to answer are: * Dose the use of continuous glucose monitoring system improve glucose control in older adults with type 2 diabetes treated with oral antidiabetic drugs only? * Dose the use of continuous glucose monitoring system affect psychological outcomes in older adults with type 2 diabetes treated with oral antidiabetic drugs only? Researchers will compare continuous glucose monitoring to standard blood glucose monitoring to see if continuous glucose monitoring works better in glucose management. Participants will: * Wear continuous glucose monitoring every 2 months or standard blood glucose monitoring for 6 months * Visit the clinic once every 2 months for follow-up * Keep a diary of their blood glucose when continuous glucose monitoring was not used
CONDITIONS
Official Title
Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 260 years at the time of screening
- Diagnosed with type 2 diabetes mellitus
- Treated with two or more oral antidiabetic drugs with a stable regimen during the 3 months prior to entry
- Suboptimal glycemic control with HbA1c 27 7.5% and 264 10% at screening or within 30 days prior
- Has a smartphone compatible with CGM and BGM systems
- Willing and able to provide written informed consent
- At least 240 hours (10 out of 14 days) of sensor glucose data from blinded CGM pre-randomization phase
You will not qualify if you...
- Use of insulin or GLP-1 receptor agonists within 3 months prior to screening
- Use of any CGM device within 3 months prior to screening
- Unable to tolerate tape adhesive around sensor placement or allergy to adhesive or serious skin diseases around sensor area
- Considered unsuitable due to dementia, psychiatric disorders, extreme visual or hearing impairment
- Planned surgery or procedures within next 6 months that may interfere with follow-up
- Current or expected acute glucocorticoid use affecting glycemic control
- Estimated glomerular filtration rate (eGFR) < 30 ml/min/1.73m2
- Participation in other clinical trials within 3 months prior to screening or during study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 15 locations
1
Shenzhen Jiangangshan Health Service Center
Shenzhen, Guandong, China, 518000
Actively Recruiting
2
Shenzhen Fifth Avenue Health Service Station
Shenzhen, Guangdong, China, 518000
Actively Recruiting
3
Shenzhen Haifu Health Service Station
Shenzhen, Guangdong, China, 518000
Actively Recruiting
4
Shenzhen Haile Huafu Health Service Station
Shenzhen, Guangdong, China, 518000
Actively Recruiting
5
Shenzhen Haiyu Health Service Station
Shenzhen, Guangdong, China, 518000
Actively Recruiting
6
Shenzhen Jiaan Health Service Station
Shenzhen, Guangdong, China, 518000
Actively Recruiting
7
Shenzhen Jiari Mingju Health Service Station
Shenzhen, Guangdong, China, 518000
Actively Recruiting
8
Shenzhen Xinan Lake Health Service Station
Shenzhen, Guangdong, China, 518000
Actively Recruiting
9
Shenzhen Xingdong Health Service Station
Shenzhen, Guangdong, China, 518000
Actively Recruiting
10
Shenzhen Zhongliang Chuangxin Health Service Station
Shenzhen, Guangdong, China, 518000
Actively Recruiting
11
Shenzhen Buxin Community Health Service Center
Shenzhen, Guangdong, China
Actively Recruiting
12
Shenzhen Dalang Community Health Service Center
Shenzhen, Guangdong, China
Actively Recruiting
13
Shenzhen Haihua Community Health Service Center
Shenzhen, Guangdong, China
Actively Recruiting
14
Shenzhen Haile Community Health Service Station
Shenzhen, Guangdong, China
Actively Recruiting
15
Shenzhen Pingzhou Community Health Service Center
Shenzhen, Guangdong, China
Actively Recruiting
Research Team
J
Jian Zhou, Prof., Dr., Ph.D
CONTACT
Y
Yaxin Wang, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here